McKesson Corporation (MCK) cash flow statement

Health Care Distributors · NYSE · Health Care

$1,092 -1.21% Close Nov 17, 2026 Live

TrendArc score 84 of 100 · Health 7.7 · Momentum 9.1 · Moat 7.2 · scored Nov 17, 2026 · How the score works

Free cash flow, fiscal year to March 31, 2026

$5.4 billione

up 3.5% from the year beforee

McKesson generated $5.4 billione of free cash flow in the fiscal year to March 2026: $6.2 billion of cash from operations less $745 million of capital spending. That was 1.3% of revenuee, against 1.5%e the year before. Over the last four quarters, to September 30, 2026, it was $6.9 billione. In the fiscal year to March 2026, capital spending includes software and other intangible assets beyond the property and equipment purchases in its filing; on property and equipment alone, free cash flow that year was $5.7 billion.

What stands out

  • Diluted shares outstanding fell 22.7% over the five fiscal years to March 2026.
  • Cash dividends paid rose in each of the last five fiscal years, from $276 million to $381 million in total.

Each sentence is written by a fixed rule from the figures on this page.

Free cash flow and net income, the last 10 fiscal years

-$6.00B-$4.00B-$2.00B$2.00B$4.00B$6.00B2017201820192020202120222023202420252026$4.18BeFree cash flow $5.41BeNet income $4.76B-$6.00B-$4.00B-$2.00B$2.00B$4.00B$6.00B20182020202220242026Free cash flow $5.41BeNet income $4.76B

Fiscal years, each labelled by the calendar year it ended in. Every figure is in the statement below.

Where the cash wentFiscal year to March 31, 2026

  1. Cash from operations 6.16
  2. Capital spendinge -0.74
  3. Free cash flowe 5.41
  4. Businesses bought and sold, net -2.59
  5. Net share repurchases -4.66
  6. Dividends -0.38
  7. Debt and other 0.33
  8. Net change in cash -1.89

In billions of US dollars. Outflows are grey, not red: a buyback is not a loss. "Debt and other" closes the gap to the reported change in cash. Buying marketable securities moves cash into short-term investments; the balance sheet shows both.

Cash flow statement, the last 10 fiscal years

In billions of US dollars. Each column is a fiscal year, named by the month it ended; the first column adds up the last four quarters. Cash paid out is a negative number.
Fiscal year toLast 4 quarters
to Sep 2026
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Operating activities
Net income4.763.293.003.561.11-4.540.900.030.075.07
Depreciation and amortisation0.990.880.860.861.001.221.290.950.950.91
Cash from operations7.506.166.084.315.164.434.544.374.044.344.74
Investing activities
Capital spending-0.64e-0.74e-0.86e-0.69e-0.56e-0.54e-0.64e-0.51e-0.56e-0.58e-0.56e
Businesses bought and sold, net-2.590.15-0.230.210.570.36-0.10-0.80-2.39-2.78
Investments bought and sold, net0.000.000.000.000.000.000.000.000.000.00
Other investing-0.10-0.03-0.16-0.19-0.13-0.140.02-0.02-0.020.07
Cash from investing-3.43-0.73-1.07-0.54-0.09-0.41-0.58-1.38-2.99-3.27
Financing activities
Debt issued or repaid, net0.78-0.020.06-0.28-1.33-0.54-0.30-0.02-1.060.39
Shares issued less bought back-6.68-4.66-3.04-2.91-3.48-3.30-0.65-1.82-1.56-1.58-2.19
Dividends paid-0.40-0.38-0.34-0.31-0.29-0.28-0.28-0.29-0.29-0.26-0.25
Other financing-0.37-0.55-0.17-0.32-1.41-0.23-0.32-0.35-0.18-0.02
Cash from financing-4.63-3.96-3.34-4.37-6.32-1.69-2.73-2.23-3.08-2.07
Exchange rate effect0.02-0.020.010.030.06-0.06-0.02-0.120.15-0.14
Net change in cash-1.891.37-0.09—b—b2.371.040.31-1.58-0.74
Free cash flow
Free cash flow6.87e5.41e5.23e3.63e4.60e3.90e3.90e3.87e3.48e3.77e4.18e
Free cash flow margin1.6%e1.3%e1.5%e1.2%e1.7%e1.5%e1.6%e1.7%e1.6%e1.8%e2.1%e
Free cash flow per share$43.59e$40.80e$27.05e$32.36e$25.30e$24.29e$21.30e$17.63e$18.01e$18.75e

b: the company's reported lines do not add up to the change in cash in our data for that year, so it is left out.

e: capital spending in our data includes software and other intangible assets beyond the property and equipment purchases in the company's filing, so free cash flow in the marked years is lower than on property and equipment alone. The last four quarters come from the same capital spending line and are marked as well.

Shares issued less bought back is the cash from shares sold less the cash paid for shares bought back (negative when more was bought back), and includes tax withheld when employees' shares vest. Working capital and other items is cash from operations less net income, depreciation and amortisation, and stock-based pay (calculated by TrendArc). Company filings as standardised by Tiingo; calculations by TrendArc. Rebuilt nightly.

McKesson against its peers

CompanyFiscal year toFree cash flowFree cash flow margin
Veeva SystemsVEEV Jan 2026$1.39B43.4%
HCA HealthcareHCA Dec 2025$7.69B10.2%
UnitedHealth GroupUNH Dec 2025$16.1B3.6%
CignaCI Dec 2025$8.39B3.1%
CVS HealthCVS Dec 2025$7.81B1.9%
Cardinal HealthCAH Jun 2026$4.56B1.8%
Elevance HealthELV Dec 2025$3.17B1.6%
McKessonMCK Mar 2026$5.41Be1.3%e
HumanaHUM Dec 2025$398M0.3%
Peer median2.5%

Each company's newest fiscal year; some end in other months. The peers are the stock card's peer group.

Next

Follow McKesson with a free account.

A watchlist, price alerts and saved chart layouts. No card needed.

Sign up free

No forecast, no recommendation. This page describes McKesson Corporation from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Nov 17, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.

The TrendArc score, from 0 to 100, combines three pillars measured from published data, Health (business quality over the last twelve months), Momentum (the price against its moving averages, its 52-week high and the market) and Moat (durability over five years), with the share price's long-run trend. It describes the company as it stands today. It is not a forecast or a recommendation.